Navigation Links
Hepatitis E research receives funding
Date:10/17/2010

by Dr Harry Dalton and his team and represents a bright start for ECEHH bringing research funding in to Cornwall."

Professor Janice Kay, Senior Deputy Vice Chancellor of the University of Exeter, said: "This is an important piece of research that will contribute significantly to enhancing the health not only of people in Cornwall, but also elsewhere in the world. It's great to see this achievement of Dr Harry Dalton and his team so early in the development of the ECEHH."

The University of Plymouth is a founding partner of the Peninsula College of Medicine and Dentistry. University of Plymouth Vice-Chancellor, Professor Wendy Purcell, said: "This award will see breakthrough life saving research being led right here in Cornwall, which is a very exciting development for the health and the wealth of the region. It is world-class research such as this - with direct translational patient benefits - which is putting PCMD on the map as one of the leading medical schools in the UK."

Sue Brownlow, Director of Combined Universities in Cornwall said: "ECEHH was established to be an internationally recognised centre of excellence for research and this grant is a mark of its success. It demonstrates what partnership working can bring to Cornwall."

Carleen Kelemen, Director of the Convergence Partnership Office for Cornwall and the Isles of Scilly, added: "The importance and outreach of this research and manufacture of a solution into the health sector is critical in placing Cornwall on the international map as place where innovation and the application of collective knowledge makes a difference to all."


'/>"/>

Contact: Andrew Gould
andrew.gould@pms.ac.uk
44-139-268-6107
The Peninsula College of Medicine and Dentistry
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. First clinical trials successfully completed on potent new hepatitis C drug
2. New antiviral drug shows promise for dramatic improvement in hepatitis C treatment
3. New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment
4. Tattooing linked to higher risk of hepatitis C: UBC study
5. Misuse of anesthesia could cause hepatitis virus transmission
6. Depression overlooked in patients with hepatitis C; compromising HCV therapy
7. Silencing hepatitis B virus prevent recurrence of liver cancer
8. Success of Hepatitis C Drugs May Depend on Gene Variant
9. New study confirms link between nonalcoholic steatohepatitis and liver cancer
10. EU gives green light for while-you-wait hepatitis B test
11. Trials begin on potent new hepatitis C drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... treating stroke victims has been "time equals brain." That,s because ... a drug that dissolves the stroke-causing blood clot can make ... or lost. , But specific information has been ... drug known as a tissue plasminogen activator, or tPA ... most common type of stroke. , Now, a ...
(Date:6/19/2013)... Loyola University Chicago Niehoff School of Nursing researcher has ... Vitamin D can improve mood in women with diabetes ... whether vitamin D supplementation can reduce blood pressure and ... is from the National Institute of Nursing Research at ... M. Penckofer, PhD, RN and colleagues hypothesize that women ...
(Date:6/19/2013)... 19, 2013 AquaPrint Solutions in Thomson, IL ... Grub with a newly-designed Harley Davidson motorcycle gas tank. A ... Solutions with an idea of taking a split tank motorcycle ... and transforming it into a work of art. , ... Grub several toilet seats that had been dipped in a ...
(Date:6/19/2013)... FL (PRWEB) June 19, 2013 Fit Body ... Andrea Laing recently held a charity boot camp in order ... fibrosis. The fitness boot camp franchise hosted the ... to 11 a.m. with 75 boot camp participants and collected ... charity boot camp marks the second fundraiser held for Orlando ...
(Date:6/19/2013)... Salt Lake City, UT (PRWEB) June 19, 2013 ... their expanded BRCA1 and BRCA2 testing service , ... genes. Analysis is available individually, or as part of ... up to seventeen additional genes with known links to ... TP53, CDK4, STK11, SMAD4, BMPR1A, CDH1, MET, FH, FLCN, ...
Breaking Medicine News(10 mins):Health News:Timely treatment after stroke is crucial, UCLA researchers report 2Health News:Timely treatment after stroke is crucial, UCLA researchers report 3Health News:Loyola receives $1.5 million grant to study vitamin D for diabetes and depression 2Health News:AquaPrint Solutions Transforms Harley Davidson Gas Tank into a Work Of Art for Poopy’s Pub & Grub 2Health News:Fit Body Boot Camp in Orlando Held Successful “Brent Can Breathe” Charity Boot Camp with Proceeds Going to Support Orlando Local Brent Snyder with Cystic Fibrosis 2Health News:Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel 2Health News:Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel 3
... one million families offering strategies for living a healthier ... Dr. Jamie McManus, Shaklee Corporation,s Chief Medical Officer, ... promote an opportunity that seeks to offer better health ... The Infinite Possibilities tour comes to the Radisson Hotel ...
... to a Healthier, More Productive PracticeNEWBERG, Ore., Feb. ... technology and is well-positioned to fit small spaces ... offers customers a mid-level platform choice that,s lower ... the high performance, service, and support that distinguish ...
... people ignore the ,whisper, of trouble , , FRIDAY, Feb. 27 ... stroke, you,d seek immediate medical attention. But what if your ... experience vague symptoms of a stroke suffer mental and physical ... , The implicit message? Don,t wait for the worst ...
... MEMPHIS, Tenn., Feb. 27 Smith & Nephew, Inc.,(NYSE: ... Trauma today announced the,introduction of a metal liner option ... system used in hip replacement and resurfacing,procedures. , ... by the Food and Drug Administration,for use with the ...
... February 26, 2009 Contrary to conventional medical wisdom, ... shows that healthy elderly patients with severe to profound ... cochlear implants with minimal risk. "Due to concerns ... with hearing loss are not receiving the implants which ...
... the National Hospice and Palliative Care Organization released ... Medicare Payment Advisory Commission,s (MedPAC) March report to ... Medicare hospice benefit.Each year, more than 1.4 million ... Medicare hospice benefit is responsible for millions of ...
Cached Medicine News:Health News:Shaklee Helps Create Healthier Lives With Its Infinite Possibilities Tour 2Health News:New A-dec 300(TM) Offers Dentists an Innovative Equipment Solution 2Health News:Even Mild Strokes Can Do Harm 2Health News:Even Mild Strokes Can Do Harm 3Health News:Smith & Nephew Introduces Metal Liner Option for the Modular R3(TM) Acetabular Cup System 2Health News:Smith & Nephew Introduces Metal Liner Option for the Modular R3(TM) Acetabular Cup System 3Health News:NYU Langone Medical Center study shows that cochlear implant surgery is safe for the elderly 2Health News:NHPCO Statement on MedPAC Recommendations to Congress 2Health News:NHPCO Statement on MedPAC Recommendations to Congress 3
(Date:6/19/2013)... , June 19, 2013   Nektar Therapeutics (Nasdaq: ... a human abuse liability (HAL) study for NKTR-181, ... entry into the brain.  This slow rate of entry is ... abuse of and addiction to current opioid analgesics. 1 ... was rated similar to placebo in "drug liking" and "feeling ...
(Date:6/19/2013)... Calif. , June 19, 2013 BD Biosciences, ... BDX ), a leading global medical technology company, today ... Analyzer , the latest in its line of high-performance research ... Analyzer delivers high-performance multicolor analysis with the most compact footprint ... 73.7 cm) and a height of 30" (76.2 cm). Recognizing ...
(Date:6/19/2013)... , June 19, 2013 NeuroDerm, ... study in volunteers, and preliminary results from a phase ... presented at the 2013 International Congress of Parkinson,s Disease ... drug formula under development for continuous administration through a ... plasma concentrations. ND0612 has been shown in ...
Breaking Medicine Technology:Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6
... Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR ... estimates that 353 new, paid Acthar prescriptions for the treatment ... quarter, up 66% from the year ago period and up ... 6,666 vials of the company,s principal drug, H.P. Acthar® Gel, ...
... 2011 - Bayer HealthCare Pharmaceuticals has become aware of a ... and swabsticks manufactured by the Triad Group and marketed under ... wants to ensure that U.S. patients and physicians using Bayer,s ... The recall of the Triad Group alcohol prep products ...
Cached Medicine Technology:Questcor Pharmaceuticals Reports Strong Finish to 2010 2Questcor Pharmaceuticals Reports Strong Finish to 2010 3Questcor Pharmaceuticals Reports Strong Finish to 2010 4Questcor Pharmaceuticals Reports Strong Finish to 2010 5Important Information for Betaseron® (interferon beta 1-b) Consumers Regarding Triad Group's Alcohol Prep Products 2Important Information for Betaseron® (interferon beta 1-b) Consumers Regarding Triad Group's Alcohol Prep Products 3
Lumicon 48 mm red filter....
Heavy duty, all purpose illuminator available in blue and green. Unique Clip Switch automatically turns off when returned to pocket. Pre-focused lens tip Heine XHL Halogen bulb for bright, concentra...
... A child-friendly vision test ... takes just seconds. Welch ... first objective, accurate vision ... early detection of refractive ...
... is a black and white ... by people who have visual ... control selector, the Classic can ... black text on a white ...
Medicine Products: